MULICA MICHAEL C, AC, reported a transaction classified as grant at DNA X, Inc. involving 50000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 54071.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
Acting CEO
Represents the grant of restricted stock units that vest in equal monthly installments over a one-year period following the date of the grant, subject to the Reporting Person's continued service to th…
Consists of (i) 4,071 shares of common stock and (ii) 50,000 unvested restricted stock units.
The number of securities reported herein reflects the effects of a 1-for-18 reverse stock split effected by the Issuer on October 27, 2025, which was exempt from reporting pursuant to Rule 16a-9.
0 other filings
0 recent txs